Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Memphasys Ltd ( (AU:MEM) ) has shared an announcement.
Memphasys Limited has notified the ASX of the issue of 7,000,000 unlisted options under an employee incentive scheme, which are not intended to be quoted on the exchange and will be treated as unquoted equity securities. The grant of these options reflects the company’s continued use of equity-based incentives to align staff and management interests with shareholders, potentially impacting future capital structure through option exercises and supporting talent retention in a competitive biotech and medical technology sector.
The most recent analyst rating on (AU:MEM) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Memphasys Ltd stock, see the AU:MEM Stock Forecast page.
More about Memphasys Ltd
Memphasys Limited is an ASX-listed company, trading under the code MEM. While this announcement does not describe its operations, Memphasys develops and commercialises reproductive and related biomedical technologies and products for the healthcare and life sciences markets.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$16.12M
For detailed information about MEM stock, go to TipRanks’ Stock Analysis page.